Pharma Journalist -

Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.…
Read More...

Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, announced submission of a new drug application (NDA) for Solosec™…
Read More...

Ethypharm announced that it has signed a definitive agreement to acquire Martindale Pharma. Martindale Pharma is a leading UK-based specialty pharmaceutical company providing…
Read More...

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei…
Read More...

Eli Lilly and Company and CoLucid Pharmaceuticals, Inc. announced an agreement for Lilly to acquire CoLucid for $46.50 per share or approximately $960 million. This all-cash transaction…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc., a privately-held biopharmaceutical company committed to developing medicines that transform the lives of people with…
Read More...

MilliporeSigma announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component…
Read More...

Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne…
Read More...

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...

Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with…
Read More...